122 related articles for article (PubMed ID: 35840157)
1. Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial.
Schneeberger EE; Citera G; de Leon DP; Szumski AE; Kwok K; Cutri M; Dougados M
J Rheumatol; 2022 Oct; 49(10):1100-1108. PubMed ID: 35840157
[TBL] [Abstract][Full Text] [Related]
2. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS).
Solmaz D; Yildirim T; Avci O; Tomas N; Akar S
Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454
[TBL] [Abstract][Full Text] [Related]
3. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
[TBL] [Abstract][Full Text] [Related]
4. Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial.
Van den Bosch F; Wei JC; Nash P; Blanco FJ; Graham D; Zang C; Arthur E; Borlenghi C; Tsekouras V; Vlahos B; Deodhar A
J Rheumatol; 2023 Apr; 50(4):478-487. PubMed ID: 36379575
[TBL] [Abstract][Full Text] [Related]
5. Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.
Di Carlo M; Lato V; Carotti M; Salaffi F
Health Qual Life Outcomes; 2016 May; 14():78. PubMed ID: 27188166
[TBL] [Abstract][Full Text] [Related]
6. Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients.
Bansal N; Duggal L; Jain N
J Clin Diagn Res; 2017 Sep; 11(9):OC06-OC09. PubMed ID: 29207750
[TBL] [Abstract][Full Text] [Related]
7. Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR.
Maksymowych WP; Claudepierre P; de Hooge M; Lambert RG; Landewé R; Molto A; van der Heijde D; Bukowski JF; Jones H; Pedersen R; Szumski A; Vlahos B; Dougados M
Arthritis Res Ther; 2021 Jan; 23(1):43. PubMed ID: 33514428
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of novel disease activity indices for ankylosing spondylitis.
Sundaram TG; Muhammed H; Aggarwal A; Gupta L
Rheumatol Int; 2020 Nov; 40(11):1843-1849. PubMed ID: 32757024
[TBL] [Abstract][Full Text] [Related]
9. SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis.
Schneeberger EE; Zamora N; Citera G
Clin Rheumatol; 2016 Nov; 35(11):2865-2866. PubMed ID: 27357718
[No Abstract] [Full Text] [Related]
10. Discriminant Capacity of Clinical Efficacy and Nonsteroidal Antiinflammatory Drug-sparing Endpoints, Alone or in Combination, in Axial Spondyloarthritis.
Dougados M; Wood E; Gossec L; Dubanchet A; Logeart I; van der Heijde D
J Rheumatol; 2015 Dec; 42(12):2361-8. PubMed ID: 26568588
[TBL] [Abstract][Full Text] [Related]
11. A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis.
Sommerfleck FA; Schneeberger EE; Buschiazzo EE; Maldonado Cocco JA; Citera G
Clin Rheumatol; 2012 Nov; 31(11):1599-603. PubMed ID: 22895877
[TBL] [Abstract][Full Text] [Related]
12. Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study.
Dougados M; van der Heijde D; Tsai WC; Saaibi D; Marshall L; Jones H; Pedersen R; Vlahos B; Tarallo M
Health Qual Life Outcomes; 2020 Jan; 18(1):4. PubMed ID: 31900174
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial.
van der Heijde D; Braun J; Dougados M; Sieper J; Pedersen R; Szumski A; Koenig AS
Rheumatology (Oxford); 2012 Oct; 51(10):1894-905. PubMed ID: 22772319
[TBL] [Abstract][Full Text] [Related]
14. Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Buß B; Freundlich B; Lange E; Alten R; Rudwaleit M; Sieper J
J Rheumatol; 2014 Oct; 41(10):2034-40. PubMed ID: 25028375
[TBL] [Abstract][Full Text] [Related]
15. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
[TBL] [Abstract][Full Text] [Related]
16. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Health Outcomes with Etanercept Treatment in Patients with Early Nonradiographic Axial Spondyloarthritis.
Dougados M; Tsai WC; Saaibi DL; Bonin R; Bukowski J; Pedersen R; Vlahos B; Kotak S
J Rheumatol; 2015 Oct; 42(10):1835-41. PubMed ID: 26276968
[TBL] [Abstract][Full Text] [Related]
18. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.
Maksymowych WP; Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Van den Bosch F; Logeart I; Wajdula J; Jones H; Marshall L; Bonin R; Pedersen R; Vlahos B; Kotak S; Bukowski JF
Ann Rheum Dis; 2016 Jul; 75(7):1328-35. PubMed ID: 26269397
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Etanercept in Nonradiographic Axial Spondyloarthritis by Stratified C-Reactive Protein Levels.
Tam HKJ; Nash P; Robinson PC
ACR Open Rheumatol; 2021 Oct; 3(10):699-706. PubMed ID: 34405589
[TBL] [Abstract][Full Text] [Related]
20. Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study.
Park JW; Kim HA; Shin K; Park YB; Kim TH; Song YW; Lee EY
Arthritis Res Ther; 2019 Jul; 21(1):163. PubMed ID: 31272498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
